Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-000350

CEO and CFO bought 2,000 shares at $11.97 ($23,940)

From the SEC's structured data for this filing

Trades in this filing

Patel Snehal · CEO and CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-01-02 Purchase : show line 1 in the form +2,000 $11.97 $23,940 5,543,702 D
Open-market purchases · 2,000 sh · avg $11.97 · $23,940
Loading xslF345X05/ownership.xml…